Traws Pharma, Inc. (TRAW)
Pharmaceutical Preparations · Healthcare · $167M
Intrinsic Value (Consensus)
$9.65
Current Price
$16.40
Margin of Safety
-41.2%
41.2% Above Intrinsic Value
Value: $10
Price: $16
Valuation Model Estimates
Current Price: $16.40
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$4.58
Earnings Power Value
$7.96
Relative Value (P/E)
$16.40
Dividend Discount Model
Not applicable
—
Consensus Value
$9.65
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $0.82
- EPS (Forward)
- $0.86
- Book Value
- $1.14
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 79.2%
- Debt/Equity
- —
- Revenue Growth
- 1134.5%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance